Aceragen Inc (ACGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACGN | AZN | AMGN | GILD | VRTX |
| Company | Aceragen Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4330 | 90.76 | 339.70 | 122.85 | 457.35 |
| High | 0.4411 | 90.76 | 339.70 | 122.85 | 457.35 |
| Low | 0.3800 | 90.76 | 339.70 | 122.85 | 457.35 |
| Latest | 0.3800 | 90.76 | 339.70 | 122.85 | 457.35 |
| Change | -0.0610 | +0.73 | -0.46 | +0.23 | -0.01 |
| % Change | -13.83% | +0.81% | -0.14% | +0.19% | unch |
| Volume | 53,000 | 257,121 | 1,231 | 1,978 | 432 |
| 20-Day Average Volume | 203,340 | 5,191,351 | 2,739,007 | 6,626,929 | 1,368,152 |
| Previous Close | 0.4410 | 90.03 | 340.16 | 122.62 | 457.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6048 | 89.86 | 337.98 | 124.43 | 433.08 |
| 20-Day Raw Stochastic | 3.11% | 66.77% | 79.37% | 49.44% | 88.63% |
| 20-Day Relative Strength | 28.34 | 60.56 | 61.48 | 50.96 | 64.10 |
| Weighted Alpha | -94.15 | +38.06 | +28.74 | +31.54 | +3.49 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 80% Buy | 40% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 100% Buy | 80% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 64% Buy | 56% Buy | 100% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.38% since 08/14/23 | -2.11% since 11/28/25 | -1.67% since 11/28/25 | -2.38% since 11/28/25 | +5.47% since 11/28/25 |
| Low | 0.3601 on 08/18/23 | 89.77 on 12/04/25 | 336.25 on 12/01/25 | 122.40 on 12/04/25 | 423.45 on 12/01/25 |
| High | 0.4770 on 08/17/23 | 92.98 on 12/01/25 | 346.38 on 12/03/25 | 126.23 on 12/01/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | -61.23% since 07/21/23 | +11.84% since 11/05/25 | +6.20% since 11/05/25 | +0.22% since 11/05/25 | +9.68% since 11/05/25 |
| Low | 0.3601 on 08/18/23 | 83.37 on 11/06/25 | 312.52 on 11/06/25 | 117.13 on 11/10/25 | 406.67 on 11/07/25 |
| High | 1.0100 on 07/24/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -77.38% since 05/19/23 | +11.09% since 09/05/25 | +19.76% since 09/05/25 | +6.78% since 09/05/25 | +15.46% since 09/05/25 |
| Low | 0.3601 on 08/18/23 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 1.8765 on 06/16/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -92.29% since 02/21/23 | +25.45% since 06/05/25 | +18.32% since 06/05/25 | +11.22% since 06/05/25 | +3.05% since 06/05/25 |
| Low | 0.3601 on 08/18/23 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 5.3700 on 05/03/23 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,201 | 279,221,376 | 183,169,696 | 152,132,192 | 116,040,920 |
| Shares Outstanding, K | 8,424 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 4,860,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -23,360,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 2,470,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -21,870,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.14 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.94 on 06/29/23 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 07/04/24 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.88 | 15.79 | 15.26 | 30.25 |